Following a series of futures additions and the release of offensive tackle Chukwuma Okorafor, the New England Patriots have now made their first player re-signing of the 2025 offseason. Defensive tackle Jeremiah Pharms Jr. was retained on a reported two-year contract extension.
Pharms Jr., a former undrafted free agent who originally arrived in 2022, was coming off the best season of his career. Originally set to enter exclusive-rights free agency in March, he will instead be part of the team through the 2026 season.
What does the signing mean for the Patriots, though?